Heat Biologics
Get Full AccessDescription
- Heat Biologics is a clinical-stage company focused on developing its proprietary ImPACT (Immune Pan-Antigen Cytotoxic Therapy), a fully allogeneic (off-the-shelf) cell-based immunotherapy for use in the treatment of a wide range of cancers.Heat's ImPACT therapy is a first-in-class, fully human immunotherapy that functions as both an immune stimulator and an antigen-delivery system. ImPACT effectively transforms living allogeneic cells into osmotic pumps that continuously secrete cancerous antigens to robustly stimulate the immune system against the targeted cancer. ImPACT therapy is applicable to a wide range of cancers.Heat is currently conducting two Phase 2 clinical trials with its HS-110 to treat Non-Small Cell Lung Cancer (NSCLC) and its HS-410 to treat bladder cancer.
-
Headquarters:801 Capitola Drive , Durham, North Carolina, United States
More -
Phone Number: +1 919-240-7133
-
Website: https://www.heatbio.com
-
Employees:13
-
Revenue:$10 - 50M
-
Legal Name:Heat Biologics
-
Heat Biologics's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Heat Biologics
-
Where are Heat Biologics's Headquarters?
Heat Biologics's Headquarters are in 801 Capitola Drive ,Durham,North Carolina,United States
-
What is Heat Biologics's phone number?
Heat Biologics's phone number is +1 919-240-7133
-
What is Heat Biologics's official website?
Heat Biologics's official website is https://www.heatbio.com
-
What is Heat Biologics's Revenue?
Heat Biologics's revenue is $10 - 50M
-
What is Heat Biologics's NAICS code?
Heat Biologics's NAICS code is 325412
-
How many employees are working in Heat Biologics
Heat Biologics has 13 employees
-
What is Heat Biologics's Industry?
Heat Biologics is in the industry of Biotechnology
-
Who is Heat Biologics's CEO?
Heat Biologics's CEO is Jeff Wolf

